RDY (Dr. Reddy's Laboratories Limited American Depositary Shares) Stock Analysis - AI Report

Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) is a publicly traded Healthcare sector company. As of May 21, 2026, RDY trades at $13.63 with a market cap of $11.32B and a P/E ratio of 0.00. RDY moved +1.23% today. Year to date, RDY is -1.37%; over the trailing twelve months it is -6.00%. Its 52-week range spans $12.19 to $16.19. Analyst consensus is sell with an average price target of $0.00. Rallies surfaces RDY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on RDY?

Rallies AI research for RDY combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

RDY Key Metrics

Key financial metrics for RDY
MetricValue
Price$13.63
Market Cap$11.32B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.11%
52-Week High$16.19
52-Week Low$12.19
Volume10
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest RDY News

RDY Analyst Consensus

1 analysts cover RDY: 0 strong buy, 0 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is sell. Average price target: $0.00.

Common questions about RDY

What is the AI research view on RDY?
Rallies AI research for RDY combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for RDY?
Rallies AI research for RDY combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is RDY research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RDY. It does not provide personalized investment advice.
RDY

RDY